Experts in the field of antimicrobial resistance (AMR) weigh in on the latest innovations in the space and offer their thoughts on what must happen to keep antimicrobial-resistant superbugs from emerging in the future.
Having a steady pipeline of new antimicrobial drugs is necessary to prevent drug-resistant superbugs, but finding the proper funding for research and development is a challenge.